BAXTER INTERNATIONAL INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.2 | $10.6 | $10.4 | $10.1 | $12.1 |
| Operating income | -$0.3 | $<0.1 | $0.7 | -$2.8 | $1.4 |
| Net income | -$1.0 | -$0.6 | $2.7 | -$2.4 | $1.3 |
| Balance Sheet | |||||
| Total debt | $9.5 | — | — | — | — |
| Cash Flow Statement | |||||
| Free cash flow | $0.3 | $0.6 | $1.3 | $0.8 | $1.5 |
| Dividends | $0.3 | $0.6 | $0.6 | $0.6 | $0.5 |
| Share repurchases | — | $0.0 | $0.0 | $<0.1 | $0.6 |
Shares outstanding 517.0M · Free float 95.0%
Annual filing data through FY ended December 31, 2025; float as of September 14, 2026.
Earnings
Other Coverage
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
September 28, 2026
FDA
Baxter Recalls Saline and Dextrose Bags Over Particles
August 31, 2026
FDA
Baxter Recalls Duo-Vent Solution Sets
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
July 20, 2026
FDA
Baxter Recalls Hillrom Volara Patient Circuits
July 20, 2026
FDA
Baxter Recalls Hillrom Volara Patient Circuit
July 20, 2026
FDA
Baxter Recalls Hillrom Volara Circuit Kits in Class I Action
July 20, 2026
FDA
Baxter Recalls Hillrom VOLARA Circuit Kit
July 16, 2026
Small-Cap Signal
AI Infrastructure Pivot Trumps Legacy Cloud Resale